Right Target, Wrong Mechanism: Mechanism Inheritance as a Structural Failure Mode in the Clinical Validation of Traditional Medical Claims

Clinical research on traditional medical claims is widely characterised as suffering from poor methodological quality: small samples, weak blinding, absent preregistration. This paper argues that the characterisation, while accurate, is diagnostically shallow. Through three case studies drawn from the Islamic prophetic-medicine corpus (Nigella sativa, the localisation of deception in the prefrontal cortex, and camel milk in diabetes), it identifies a distinct and more consequential failure mode, termed mechanism inheritance: the traditional claim supplies both a target (a plant, a brain region, a food) and a mechanism (an account of how it works); modern validation research reliably adopts the target, but also, unreflectively, inherits the mechanism, which then propagates into study design and corrupts it. The three cases fail in three structurally distinct ways, each traceable to an inherited mechanism rather than to executional sloppiness: effect-size mis-specification (N. sativa), construct mis-specification (prefrontal cortex), and comparator mis-specification (camel milk). In each case the resulting literature is not weak evidence but non-evaluable evidence, and in each case the remedy is a change of question rather than an increase in rigour. A further distinction is drawn between literatures that are quantitatively broken (more participants would fix them) and structurally broken (a larger version of the same study reproduces the same error with greater precision). The paper further argues that validation research on traditional medicine is uniquely vulnerable to mechanism inheritance, for a reason absent from classical pharmacognosy: its motivation and often its funding derive from the tradition itself, so the traditional mechanism is retained as part of the research programme's justification rather than discarded as an incidental historical wrapper. Nineteenth-century isolation of salicin, quinine and digitalin succeeded in part because the investigators were indifferent to the traditional account. This yields a testable prediction about where inheritance should be most severe. It concludes with four design rules for mechanism-agnostic validation, and distinguishes sharply between ethnopharmacology, which generates testable hypotheses, and scriptural concordism, which does not.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-18
DOI
https://doi.org/10.5281/zenodo.24343244
Primary Topic
Complementary and Alternative Medicine Studies
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Right Target, Wrong Mechanism: Mechanism Inheritance as a Structural Failure Mode in the Clinical Validation of Traditional Medical Claims

KARIM ADAMINI EL GHOUILI
1 links
Zenodo (CERN European Organization for Nuclear Research)
Complementary and Alternative Medicine Studies
preprint

Right Target, Wrong Mechanism: Mechanism Inheritance as a Structural Failure Mode in the Clinical Validation of Traditional Medical Claims

KARIM ADAMINI EL GHOUILI
preprint en

Abstract

Clinical research on traditional medical claims is widely characterised as suffering from poor methodological quality: small samples, weak blinding, absent preregistration. This paper argues that the characterisation, while accurate, is diagnostically shallow. Through three case studies drawn from the Islamic prophetic-medicine corpus (Nigella sativa, the localisation of deception in the prefrontal cortex, and camel milk in diabetes), it identifies a distinct and more consequential failure mode, termed mechanism inheritance: the traditional claim supplies both a target (a plant, a brain region, a food) and a mechanism (an account of how it works); modern validation research reliably adopts the target, but also, unreflectively, inherits the mechanism, which then propagates into study design and corrupts it. The three cases fail in three structurally distinct ways, each traceable to an inherited mechanism rather than to executional sloppiness: effect-size mis-specification (N. sativa), construct mis-specification (prefrontal cortex), and comparator mis-specification (camel milk). In each case the resulting literature is not weak evidence but non-evaluable evidence, and in each case the remedy is a change of question rather than an increase in rigour. A further distinction is drawn between literatures that are quantitatively broken (more participants would fix them) and structurally broken (a larger version of the same study reproduces the same error with greater precision). The paper further argues that validation research on traditional medicine is uniquely vulnerable to mechanism inheritance, for a reason absent from classical pharmacognosy: its motivation and often its funding derive from the tradition itself, so the traditional mechanism is retained as part of the research programme's justification rather than discarded as an incidental historical wrapper. Nineteenth-century isolation of salicin, quinine and digitalin succeeded in part because the investigators were indifferent to the traditional account. This yields a testable prediction about where inheritance should be most severe. It concludes with four design rules for mechanism-agnostic validation, and distinguishes sharply between ethnopharmacology, which generates testable hypotheses, and scriptural concordism, which does not.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Complementary and Alternative Medicine Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon